PMID: 9183237Jun 9, 1997Paper

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group

Archives of Internal Medicine
J H AndersonR DiMarchi

Abstract

Insulin lispro is an insulin analog that was recently developed particularly for a mealtime therapy. It has a fast absorption rate and short duration of action. The efficacy of insulin lispro in the clinical therapy of patients with non-insulin-dependent diabetes mellitus (NIDDM) has not been tested. To compare insulin lispro and human regular insulin in the mealtime treatment of patients with NIDDM. A 6-month, randomized, multinational (16 countries), multicenter (80 sites) clinical trial with an open-label, crossover design was performed in 722 patients with NIDDM. Insulin lispro was injected immediately before and human regular insulin 30 to 45 minutes before the meal. Throughout the study, the postprandial rise in serum glucose levels was significantly lower during insulin lispro than human regular insulin treatment. At end point the rise (mean +/- SEM) in serum glucose levels was 30% lower at 1 hour (2.6 +/- 0.1 mmol/L [46.8 +/- 1.8 mg/ dL] for lispro vs 3.7 +/- 0.1 mmol/L [66.6 +/- 1.8 mg/dL] for human regular insulin) and 53% lower 2 hours after the test meal (1.4 +/- 0.1 mmol/L [25.2 +/- 1.8 mg/dL] for lispro vs 3.0 +/- 0.1 mmol/L [54.0 +/- 1.8 mg/dL] for human regular insulin) with insulin lispro compared with human re...Continue Reading

Citations

Nov 20, 2003·Diabetes Research and Clinical Practice·James K MaloneZvonko Milicevic
May 28, 2004·Diabetes Research and Clinical Practice·Nadia H Mohammed, Thomas M S Wolever
Dec 1, 2001·Endocrinology and Metabolism Clinics of North America·S Mudaliar, S V Edelman
Oct 20, 2009·Journal of the American Chemical Society·Youhei Sohma, Stephen B H Kent
Sep 7, 2000·European Journal of Clinical Investigation·L Monnier
Mar 7, 2001·Diabetes, Obesity & Metabolism·M R BurgeD S Schade
Nov 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·J Akram, V De Verga
May 3, 2003·Diabetes Technology & Therapeutics·Smiljana Ristic, Peter C Bates
Oct 26, 2005·Diabetes Technology & Therapeutics·Satish K Garg
Mar 18, 2011·Metabolic Syndrome and Related Disorders·Katherine EspositoDario Giugliano
Jan 30, 2004·Diabetes, Obesity & Metabolism·H de BoerL Verschoor
Jun 17, 2006·Diabetes, Obesity & Metabolism·A H Barnett
Aug 2, 2008·Diabetes, Obesity & Metabolism·E MannucciN Marchionni
Jan 6, 2009·Diabetes, Obesity & Metabolism·B SheldonJ Wright
Aug 14, 2012·Diabetes, Obesity & Metabolism·L NosekT Heise
Feb 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sumeet R SinghHeather Bennett
Mar 13, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Kristina S BoyeAodan Tynan
Dec 31, 2002·Adverse Drug Reactions and Toxicological Reviews·Maribel Salas, Jaime J Caro
Mar 20, 2003·Current Diabetes Reports·M Angelyn Bethel, Mark N Feinglos
Mar 25, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·J K MaloneB Augendre-Ferrante
Jan 30, 2009·Basic & Clinical Pharmacology & Toxicology·Rannveig Linda ThorisdottirJens Sandahl Christiansen
Apr 8, 2016·Journal of the American Medical Directors Association·Andrew R ZulloRobert J Smith
Jul 24, 1998·Annals of Medicine·V A Koivisto
Oct 10, 2012·Expert Opinion on Biological Therapy·Katherine EspositoDario Giugliano
Jul 5, 2005·Expert Opinion on Investigational Drugs·E A Gale
Jul 2, 2003·Expert Opinion on Pharmacotherapy·Vincent McAulay, Brian M Frier
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Simon Heller
Jun 25, 2002·Best Practice & Research. Clinical Gastroenterology·Anders Lindholm
Oct 17, 2013·Diabetes Research and Clinical Practice·Simona FrontoniAntonio Ceriello
Feb 3, 2012·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Kevin KaisermanJessie L Fahrbach
Mar 6, 2007·La Presse médicale·Amélie TielmansPierre-Jean Guillausseau

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.